Phase I/II Thymus Transplantation With Immunosuppression #950

Clinical trial NCT00579527 · COMPLETED

Trial details

NCT number: NCT00579527
Sponsor: Sumitomo Pharma Switzerland GmbH
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

DiGeorge Anomaly Complete DiGeorge Anomaly Complete Atypical DiGeorge Anomaly Complete DiGeorge Syndrome Complete Atypical DiGeorge Syndrome

Start date: 2005-12-19
Primary completion: 2011-12-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.